SB1454

Missouri SB1454 modifies provisions relating to alternative therapies and investigational drugs.

Missouri SB1454 modifies provisions relating to alternative therapies and investigational drugs. It prohibits action against a physician's license or a health care provider's Medicare certification based solely on their recommendation for investigational drugs, biological products, or devices. The bill defines terms such as "eligible patient," "investigational drug, biological product, or device," "terminal condition or illness," "life-threatening condition or illness," and "severely debilitating condition or illness." It also outlines conditions under which manufacturers can provide.